StockClub
IMVTImmunovant, Inc.$ --
Immunovant, Inc.

Immunovant, Inc.

IMVT

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2025/03 Filed: 2025-05-29

Total Assets

account_balance
776.2M USD
No comparison

Shareholders' Equity

savings
707.4M USD
No comparison

Equity Ratio

pie_chart
91.1%
No comparison

Book Value Per Share

paid
3.48USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
200150100500
2021
2022
2023
2024
2025

Balance Sheet Details

Item
2018
2019
2020
2021
2022
2023
2024
2025
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
713.97M
713.97M
0
2.51M
0
51.18M
767.66M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
0
942,000
942,000
0
0
7.62M
776.22M
8.56M
776.22M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
17.66M
0
0
0
15.62M
68.78M
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
0
98,000
98,000
0
-713.87M
0
68.78M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
16,000
151.57M
1.95B
-1.24B
1.46M
0
0
707.45M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.